Display options
Cite
Ozkok A, Kaymaz S, Elcioglu OC, et al. Cyclophosphamide induced early-onset interstitial lung disease. CEN Case Rep. 2012;1(2):128-129doi: 10.1007/s13730-012-0021-6.
Ozkok, A., Kaymaz, S., Elcioglu, O. C., Bakan, A., & Odabas, A. R. (2012). Cyclophosphamide induced early-onset interstitial lung disease. CEN case reports, 1(2), 128-129. https://doi.org/10.1007/s13730-012-0021-6
Ozkok, Abdullah, et al. "Cyclophosphamide induced early-onset interstitial lung disease." CEN case reports vol. 1,2 (2012): 128-129. doi: https://doi.org/10.1007/s13730-012-0021-6
Ozkok A, Kaymaz S, Elcioglu OC, Bakan A, Odabas AR. Cyclophosphamide induced early-onset interstitial lung disease. CEN Case Rep. 2012 Nov;1(2):128-129. doi: 10.1007/s13730-012-0021-6. Epub 2012 Jun 06. PMID: 28509066; PMCID: PMC5411529.
Copy Download .nbib Format: NLM
Share it on

CEN Case Rep. 2012 Nov;1(2):128-129. doi: 10.1007/s13730-012-0021-6. Epub 2012 Jun 06.

Cyclophosphamide induced early-onset interstitial lung disease.

CEN case reports

Abdullah Ozkok, Sema Kaymaz, Omer Celal Elcioglu, Ali Bakan, Ali Riza Odabas

Affiliations

  1. Department of Internal Medicine and Nephrology, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Kadikoy, Istanbul, Turkey. [email protected].
  2. Department of Internal Medicine and Nephrology, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Kadikoy, Istanbul, Turkey.

PMID: 28509066 PMCID: PMC5411529 DOI: 10.1007/s13730-012-0021-6

[No abstract available.]

Keywords: Cyclophosphamide; Interstitial lung disease; Lung fibrosis

References

  1. Ann Pharmacother. 2001 Jul-Aug;35(7-8):894-7 - PubMed
  2. Intern Med. 2003 Jan;42(1):82-7 - PubMed
  3. Nihon Jinzo Gakkai Shi. 1995 Sep;37(9):518-22 - PubMed
  4. Acta Paediatr Jpn. 1997 Jun;39(3):364-7 - PubMed

Publication Types